Dr Mariana Cervantes (MCT) was successful in obtaining funding from The National Council of Science and Technology (CONACYT) from Mexico under the Support for Postdoctoral Researchers Abroad Linked to the Consolidation of Research Groups scheme. This funding will support her postdoctoral research in circadian biology in the Curtis-Clock Lab, under the guidance of Dr Annie Curtis. The grant titled “Impact of circadian control on mitochondrial metabolism in Dendritic Cells and their implications in vaccination” was funded for $48,000 for 2 years. In this project, Dr. Cervantes will unravel the mechanisms by which the molecular clock regulates dendritic cell function with the objective to improve vaccination strategies.
This grant is awarded to Mexican Postdoctoral researchers who wish to carry out high-level research in prestigious universities worldwide.
MCT was well represented at this year’s Haematology Association of Ireland meeting in Cork. A number of PhD students and Post-docs from the Irish Centre for Vascular Biology, has their work selected for presentation at this prestigious annual meeting. Moreover, three of these presentations were awarded prizes;
Presidents Prize: Clive Drakeford, PhD student
Best Scientific Oral Presentation: Dr Sean McCluskey, PostDoc
Best Scientific Poster Presentation: Soracha Ward, PhD student
Additionally, two PhD students, Sean Patmore and Aisling Rehill, scored in the top 20% of submitted abstracts and had their work selected for oral presentations at the meeting.
This summer RCSI welcomed our very first cohort of ten international students as part of our Inaugural RCSI StAR International Summer Internship Programme. Students came from Washington University, Cornell University, University of California, Berkeley, University of Oregon, Queen’s University Belfast, University of Liverpool and TCD to spend two months in laboratories around RCSI. To mark the end of the programme we held a research symposium where students show-cased their research and experience. It was a huge success, with Kieran White, University of Liverpool winning the overall prize for the best presentation on ‘Nanotherapeutics for Glioblastoma’ (supervisor Professor Annett Byrne). Kieran has already accepted a PhD position with Prof Byrne on her GlioTrain programme. Thanks to Prof Darran O’Connor and Prof Tracy Robson (MCT) for leading this initiative.
We will also be running the StAR summer internship next year – stay tuned. Here is the link to last year’s programme which will be updated within the next month: http://www.rcsi.ie/starugprogramme
BPS DUNLOP PRIZE LECTURE Dr.Neeraj Dhaun (Bean), University of Edinburgh will deliver a lecture on ROLE OF THE INNATE IMMUNE SYSTEM IN HYPERTENSION AND ITS COMPLICATIONS
Thursday, 24th January 2019.
Albert Lecture Theatre 5:30pm – 6:30pm
Followed by Networking Wine Reception
The event is free but pre-registration is required
To register please follow the link:
For further information on the BPS Dunlop Prize Lecture visit www.bps.ac.uk
I wanted to congratulate everyone for their significant contributions to recent RCSI Research Day. MCT’s presence was strong on the day with a number of keys oral and poster presentations from across the four MCT research pillars.
In particular, a huge congratulations to:
Dr Joan Ni Gabhann for the Most Highly Cited RCSI Senior Authored Paper with Industry Collaboration 2012-2016 for her paper ‘Btk regulates macrophage polarization in response to lipopolysaccharide’.
Rebecca Watkin (PI Prof Steven Kerrigan) and Edmund Gilbert (PI Prof Gianpiero Cavalleri) who jointly won the best postgraduate oral presentation, sponsored by Bio-Sciences Limited, for their presentations on ‘S.aureus induced miR330-3p expression triggers abnormal permeability in an ex-vivo 2D model of sepsis’ and ‘The Irish DNA Atlas: Revealing Fine-Scale Population Structure and History within Ireland’, respectively.
Prof James O’Donnell (ICVB) who won the Clinician CEO Innovation Award.
Dr Ingmar Schoen for his novel Invention Disclosure.
Camille Hurley (PI Dr Darran O’Connor), Edmund Gilbert (PI Prof Gianpiero Cavalleri) and Conor Duffy (PI Claire McCoy)for winning inaugural RCSI International Secondment Awards.
Finally, well done to Dr Claire McCoy for giving an inspiring and heartfelt presentation about her SFI President of Ireland Future Research Leader Award.
On 25th January 2018 – President of Ireland, Michael D. Higgins, honoured Dr Claire McCoy with the SFI President of Ireland Future Research Leaders Award at a special ceremony in Áras an Uachtaráin in Dublin. Claire was among one of five recipients for this prestigious award and receives a total of €1.5m, which will support a team of 4 researchers; Dr Jennifer Dowling (Senior Post-Doctoral Researcher and hon. Lecturer), Dr Elizabeth John (Research Assistant), Ms Remsha Afzal (PhD student) and Mr Conor Duffy (PhD student).
Congratulating the awardees at the event in Áras an Uachtaráin President Michael D. Higgins said, “I am delighted to receive the wonderful scientists who have been granted SFI Future Research Leaders Awards. This award celebrates their scientific achievements and significant dedication. Their work is evidence of the ongoing world-class research being carried out in Ireland, positioning us as a global leader for scientific excellence.”
Congratulating the awardees, Prof Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland, said “The President of Ireland Future Research Leaders Award is designed to attract to Ireland outstanding new and emerging research talent. In supporting these talented and innovative individuals, we are delighted to recognise early career researchers who have already displayed exceptional leadership potential at the frontiers of knowledge. The development of leadership skills in these researchers early in their careers is vital to ensure research and innovation in Ireland continues to progress. Our investment highlights the importance that Science Foundation Ireland places on supporting all stages of academic careers, and on the attraction and retention of star researchers.”
The research of Dr Claire McCoy is based in the Molecular and Cellular Therapeutics Department at the Royal College of Surgeons Ireland. Her research is focused on significantly advancing current therapeutic strategies for the treatment of multiple sclerosis (MS), where Ireland has the highest global incidence. Speaking of her award, she said “Obtaining this SFI Future Research Leaders award is the highlight of my career to-date. Not only does it enable me to lead a growing research team, it will also significantly contribute to the cutting-edge research being conducted at RCSI. Most importantly, it helps to place Ireland at the forefront of multiple sclerosis research worldwide.”
Reported by SFI communications and Dr Claire McCoy
I have had an immense passion for science since I began my secondary school journey, which would be five years ago, now! I became engrossed in the subject, and intrigued in all there was to learn from it. I knew it was what I wanted to pursue as a career and that it would be a major part of my future. I couldn’t be more eager to continue on my path of science and see what it has to bring.
So, as you can imagine, when I received word of a lab safari experience in RCSI, I was ecstatic and jumped at the chance to improve my knowledge in the field of molecular and cellular therapeutics, meet new people, both those with a similar ardent spirit of science and interest in the field like myself and those who have incredible stories to share of their journeys in the field. I was also especially keen to get a glimpse of the college itself, as it is a college that really stood out to me, as a lover of science and I have followed its successes and path for years now.
Arriving outside RCSI with my mother, I was filled with joy and overwhelming adrenaline as I was about to enter the college. Upon our entrance, we were shown to a room where we received our introduction talks. We first met Tracy Robson who spoke of her role as head of the department of molecular and cellular therapeutics in RCSI and her inspirational path into the area of science and focuses on the research of cancer. Her talk had to be my most enjoyable part of the whole experience as she expressed that passion for the field is what got her to where she is today, and also going out and discovering opportunities and having the courage to ask questions. It gave me motivation and encouraged me to take all opportunities that may come my way, which will benefit me as I begin my adventure into the scientific world!
We were then introduced to Avril Hutch, head of equality and diversity at RCSI. We did an exercise in which we were shown pictures of workers in the science field and we had to guess which profession they held. It gave us a glimpse at the topic of unconscious bias, particularly in science, and as a female in science myself I greatly respected her and her focus on equality in RCSI.
After being divided into our groups, we put our goggles and lab coats on and began our safari. We firstly arrived at the station of Claire McCoy who informed us of her work, targeting miR-155 activity in macrophages to promote an anti-inflammatory function for multiple sclerosis. The work she does is fascinating and it captured my attention as she explained. She was extremely polite and helpful and all questions I had, she was more than delighted to answer.
Then, moving on we met a team who thought us all about genetics, we even got to do experiments to determine what genetic traits we had ourselves and compare within our group, which I tremendously enjoyed. Lastly, we greeted Olga and John who explained the research in biomarkers for neuroblastoma. It was an extremely gripping topic to learn about and after that sadly, it was time to leave the labs.
Following the tour of the labs, fun experiments completed and brains full of new, amazing knowledge we all received certificates and colouring books of the brain, which I absolutely loved!
Overall the experience was so special to me and every bit of it was wonderful. I feel like I’ve learned so much and can use my new-found knowledge along with my journey in science. I would like to thank RCSI for holding such an event because it is greatly appreciated by those who want to adventure it to the scientific field and those who are unsure, and I hope there will be many more like it in the future. After this whole experience, I am even more certain and passionate about working in the world of science!
Last Monday while in Amsterdam with my Mam and two sisters, a friend of mine sent a text to let me know that the 2017 Nobel Laureates in Physiology and Medicine were Hall, Rosbash and Young. They were awarded the Nobel for their work in identifying the key genes that create circadian or body clock rhythms in the fruit fly. My feet literally were stuck to the ground, it was thrilling to know that these gentlemen would get the recognition that they so deserve, but also what this will mean for the field of science that I am so passionate about. The body clock is the molecular timekeeping system that exists in practically every organism on the earth and in every cell in our body. Simply put, it allows the cell to tell what time of day it is. Why is that important? We live on a spinning planet and because of the earth’s rotation to the sun, all life on earth has been subjected to daily periods of light and heat, dark and cold. The body clock allows us to anticipate and respond to these 24-hour predictable environmental changes and synchronises our physiology to it. For example, the body clock increases cortisol levels in the body ahead of awakening, this helps us to become active once we wake. The body clock also increases expression of digestive enzymes in the intestinal tract during daylight hours (this is why curry chips at 3am is never a great idea!).
Back in the 80’s Hall, Rosbash and Young independently isolated a gene called Period, they showed how the gene encodes a protein PER that builds up in cells at night and degrades during the day. This daily rise and fall of PER essentially allow the cell to track time of day. How thrilling it must have been for them to observe this daily change in the mRNA levels of Period gene (Figure 1- black line), all that is changing along the x-axis is the time of day.
So what does this mean three decades later? We have made great strides in understanding how the molecular clock works. We now know that the clock keeps time by a series of transcriptional-translational feedback loops. We also know that the clock controls 40% of all coding genes within the body. The body clock controls all aspects of our physiology from metabolism to immunity.
Many diseases, such as osteoarthritis and cardiovascular disease, are highly time of day dependent. Moreover, it appears that disruption of our body clocks, caused by our non-stop 24/7 lifestyle and exposure to artificial light at all times of day, is partly responsible for the increase in chronic inflammatory diseases. Unfortunately, most cell culture systems are not synchronized with the time of day, and this, in my opinion, is one of the main reasons that many researchers unknowingly neglect this field. Finally, we are making great strides in attempting to time specific treatments to the right time of day, an area called chronotherapy. Therefore, it is my hope that this increased awareness of the body clock will bring more researchers into this fascinating field. If we don’t fully understand how our body clock controls physiology and disease we will certainly be left in the dark.
Annie Curtis is a Research Lecturer and runs the Immune Clock laboratory at MCT and is fascinated by all things body clock related.
Please join me in sending congratulations to the following staff: Sudipto Das and Jennifer Dowling on their appointment as Honorary Lecturer[s] within MCT, recently approved by Academic Council.
Sudipto Das on the award of best poster presentation in the Post-doctoral researcher category for poster titled “Using next-genera-on sequencing strategies to guide precision oncology in cases with atypical clinical presentation” at the Irish Society for Human Genetics Annual Conference held at Croke Park, Dublin on 15th Sep, 2017.
Jamie Early, student with Annie Curtis, for the best short talk at the Irish Society for Immunology Annual meeting. The title of talk: The circadian clock protein BMAL1 regulates inflammation in macrophages via the NRF2 antioxidant defense pathway”.
And finally to ‘Dr’ Rana Bakhidar PhD, who successfully defended her thesis last week. The title of her thesis is ‘Nanoparticles Used in Drug Delivery and Targeting: Understanding the relationships between Nanoparticle Quality And Interaction With Platelets’. Supervisor: Dr. Sarah O’Neill and Co-supervisor, Dr Zeibun Ramtoola, School of Pharmacy,
Well done to all!
Professor & Head of Molecular & Cellular Therapeutics (MCT)
Bayer announced awards of $2 Million in Hemophilia Research and Patient-care Grants to 16 People at The International Society on Thrombosis and Haemostasis 2017, held in Berlin in July.
Congratulations to Dr. Roger Preston, Irish Centre for Vascular Biology[ICVB], (MCT) who was awarded a prestigious Special Project Award (€200,000) from the Bayer Haemophilia Award Programme to develop novel pro-hemostatic agents for the enhanced treatment of patients with haemophilia.
There was a strong representation from MCT at the ISTH Congress including Professor Dermot Kenny, Professor James O’Donnell, Dr. Roger Preston and their respective teams, and Dr. Dermot Cox, President, SSC* 2018. [*SSC:The Scientific and Standardization Committee].
Orla Willis Fox, Phd student with Dr. Roger Preston (ICVB/MCT), was awarded an ISTH Young Investigator Award for submitting one of the highest ranked abstracts. Her abstract title was ‘Inhibition of Activated Protein C Aspartyl Beta-hydroxylation Restricts Anticoagulant Function but Enhances Cytoprotective Signaling Activity’.
Professor James O’Donnell, ICVB/MCT presented an invited state-of-the-art lecture on his landmark studies on VWF and Cerebral Malaria,Dr. Michelle Lavin, ICVB/MCT on LOVIC [The Low Von Willebrand factor Ireland Cohort (LoVIC)] study, Dr. Sonia Agulia, ICVB/MCT on The Role of Sialylation in low VWF levels andSoracha Ward, ICVB/MCT gave a presentation on VWF Clearance.
Additionally, there was significant interest among the attendees in the ISTH SSC 2018 Annual Meeting which will be held in Dublin 2018; Dr. Dermot Cox, President, SSC 2018 anticipates a record attendance of 3,000 delegates for the Dublin meeting. Olwen Foley , (MCT) managed the Irish stand.